Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
about
MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer.miRNAs as potential regulators of mTOR pathway in renal cell carcinoma.Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.The role of RICTOR downstream of receptor tyrosine kinase in cancers.
P2860
Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-suppressive microRNA-218 ...... nent RICTOR in prostate cancer
@en
Tumor-suppressive microRNA-218 ...... ent RICTOR in prostate cancer.
@nl
type
label
Tumor-suppressive microRNA-218 ...... nent RICTOR in prostate cancer
@en
Tumor-suppressive microRNA-218 ...... ent RICTOR in prostate cancer.
@nl
prefLabel
Tumor-suppressive microRNA-218 ...... nent RICTOR in prostate cancer
@en
Tumor-suppressive microRNA-218 ...... ent RICTOR in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Tumor-suppressive microRNA-218 ...... nent RICTOR in prostate cancer
@en
P2093
Juanhua Tian
Xinyang Wang
P2860
P304
P356
10.18632/ONCOTARGET.14131
P407
P577
2016-12-24T00:00:00Z